Joint Formulary & PAD

Iloprost - Raynaud's Phenomenon

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous infusion
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Iloprost
Indication :
Raynaud's Phenomenon
Group Name :
Keywords :
Raynaud's disease, Raynaud's syndrome
Brand Names Include :
Ventavis
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Iloprost is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Raynaud's Phenomenon.

Committee Recommendations (1)

01 Apr 13 - Not Set
Responsible commissioners are CCGs. Iloprost for this indication is considered a RED drug and treatment should be initiated and monitored by specialists in hospitals. There should be no prescribing in primary care